Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999387 | Urologic Oncology: Seminars and Original Investigations | 2016 | 6 Pages |
Abstract
Everolimus showed limited efficacy in unselected heavily pretreated refractory TGCTs. Prolonged disease stabilization could be achieved in selected patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Michal M.D., Ph.D., Daniela Ph.D., Vera M.D., Ph.D., Jana M.D., Ph.D., Patrik M.D., Ph.D., Jan M.D., Ph.D., Zuzana M.D., Michal M.D., Katarina M.D., Ph.D., Peter M.D., Dalibor M.D., Ph.D., Stanislav M.D., Ph.D., Maria M.D., Jozef M.D., Ph.D.,